Coronary disease & ACS

Influence of Chronic Kidney Disease on Outcomes After Paclitaxel-Coated Balloon Angioplasty for Coronary In-Stent Restenosis

Circ Cardiovasc IntervPublished post hoc analysis of the AGENT IDE trial

Authors' conclusion

Among patients undergoing intervention for in-stent restenosis, the benefit of DCB versus balloon angioplasty was consistent irrespective of baseline CKD status. Baseline renal function also did not influence outcomes in the recurrent event analysis.

Study context

Population
Patients undergoing intervention for coronary in-stent restenosis, with chronic kidney disease (CKD) (estimated glomerular filtration rate <60 mL/min per 1.73 m 2 ) and without renal impairmentpatients randomized to drug-coated balloons (DCB), 149 (25%) had CKD · CKD 149
Participants
406 patients
Comparison
DCB vs balloon angioplasty
Primary endpoint
Target lesion failure:
  • Ischemia-driven target lesion revascularization (TLR)
  • Target vessel myocardial infarction
  • Cardiac death
Follow-up
2 years
Methodological detailstime-to-first-event and recurrent event methods
  • Time-to-first-event and recurrent event methods

Primary result

As reported in the abstract

Target lesion failure:
  • Ischemia-driven TLR
  • Target vessel myocardial infarction
  • Cardiac death
DCB vs balloon angioplastyHazard ratio (95% CI)
Patients with CKD: 23.6% versus 30.0%
0.70(0.35–1.39)
Patients without CKD: 28.1% versus 34.9%
0.74(0.52–1.05)

Further findings

Baseline characteristics of CKD patients

Mean estimated glomerular filtration rate (CKD)
47.3±9.2
Older, greater multivessel disease and congestive heart failure than those without CKD
No differences in clinical presentation, Mehran in-stent restenosis patterns or technical success

Recurrent events analysis

Effect of DCB not influenced by baseline renal function

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Influence of Chronic Kidney Disease on Outcomes After Paclitaxel-Coated Balloon Angioplasty for Coronary In-Stent Restenosis. Circ Cardiovasc Interv. Published 17 September 2026. doi:10.1161/circinterventions.126.016978

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.